Kenneth J. Hillan - 16 Jun 2021 Form 3 Insider Report for 23andMe Holding Co. (MEHCQ)

Role
Head of Therapeutics
Signature
/s/ Kenneth Hillan, by Kathy Hibbs, attorney-in-fact
Issuer symbol
MEHCQ
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
3
Filing time
25 Jun 2021, 17:22:30 UTC
Previous filing
07 May 2021
Next filing
11 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ME Stock Option (Right to Buy) 16 Jun 2021 Class A Common Stock, $0.0001 par value 1,100,974 $5.01 Direct F1
holding ME Stock Option (Right to Buy) 16 Jun 2021 Class A Common Stock, $0.0001 par value 917,478 $5.04 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on Februay 19, 2019.
F2 The stock options vest equally in 1/48 monthly installments beginning on September 1, 2020.

Remarks:

Exhibit List Exhibit 24 - Power of Attorney